Welcome to Multibagg AI
Log in to access personalized features
IRIS
Multibagg AI is an AI powered stock research and analysis platform. We provide data, information, content, and analytics for publicly traded Indian companies listed on NSE and BSE. AI can make mistakes, check important information.
Research powered by GOALZEN CAPITAL SERVICES PRIVATE LIMITED · SEBI Research Analyst INH000013448
Prices might be delayed by a few minutes.
Join our Exclusive Community
Join our Exclusive Community
Made with 💙 in India. © Finsky Technologies Pvt Ltd. 2026
Get instant AI-powered insights about company performance, financials, and strategy. Ask questions about trends, competition, and developments while receiving responses backed by official documents and market data, with clear attribution to source documents.
Discovery themes featuring this stockBearish
3
Neutral
3
Bullish
8
Bearish
35
Neutral
3
Bullish
8
Bearish
32
Neutral
0
Bullish
0
Bearish
3
Neutral
3
Bullish
8
Bearish
3
Neutral
3
Bullish
8
Bearish
32
Neutral
0
Bullish
0
Bearish
32
Neutral
0
Bullish
0
Bearish
32
Neutral
0
Bullish
0
Vinati Organics Limited manufactures specialty organic intermediates, monomers, polymers and additives, including world-leading ATBS and IBB and India-leading IB and butyl phenols used across polymers, pharmaceuticals and antioxidants; its plants are at Mahad and Lote Parashuram, Maharashtra and it operates a wholly-owned subsidiary Veeral Organics (VOPL) and a US-incorporated entity for global outreach.
Financially, FY26 saw stable full-year revenue around INR2,280–2,281 crores while EBITDA improved ~13–17% and PAT rose between 9–18% on standalone and consolidated bases, highlighting margin expansion and operational leverage despite flat headline sales; the company finished FY26 debt-free with a cash treasury of ~INR190 crores and recommended an INR8.50 per share dividend.
Operationally, the company completed Phase I ATBS expansion to a 50,000 MT scale and reported ATBS utilisation near 75–80%, while targeting ~15% company-level volume growth for FY27 and earmarking INR200–250 crores capex for FY27 focused on downstream, product development and debottlenecking, underscoring strong growth visibility tied to capacity investment.
Market dynamics show Vinati Organics competing against aggressive Chinese pricing and cyclic end-market destocking, yet it retains structural strengths in niche, high-purity chemistries and differentiated feedstock control; management expects antioxidants and IB/butyl-phenol downstream integration to drive medium-term revenue expansion to INR800–900 crores in the antioxidants roadmap over the next two years.
Risk and mitigation highlights include earlier IBB disruption due to geopolitical raw material constraints which is now resolved, an ongoing process reengineering at VOPL expected to restore full production by Q3 FY27, and active R&D and backward-integration moves to protect margins and secure feedstock, indicating practical risk management rather than speculative guidance.
Chemicals & Petrochemicals
Specialty Chemicals
11,092 Cr
Low Risk
24.7
35.0
1.4
3.5
1,713.35
1,062.20
Sales CAGR
Profit CAGR
ROE
ROCE
Upcoming Result Date: Oct 29, 2026
View Standalone
View Standalone
View Standalone
View Standalone
View Standalone
View Standalone
View Standalone
View Standalone
Investor Presentation
Q1 FY26
Vinati Organics Ltd (VINATIORGA) is currently trading at 1,068.50 per share. Stock prices fluctuate during market hours on NSE and BSE based on demand, company updates, and overall market conditions. Refer to the live price chart above for the most recent price movement.
Vinati Organics Limited manufactures specialty organic intermediates, monomers, polymers and additives, including world-leading ATBS and IBB and India-leading IB and butyl phenols used across polymers, pharmaceuticals and antioxidants; its plants are at Mahad and Lote Parashuram, Maharashtra and it operates a wholly-owned subsidiary Veeral Organics (VOPL) and a US-incorporated entity for global outreach. Financially, FY26 saw stable full-year revenue around INR2,280–2,281 crores while EBITDA improved ~13–17% and PAT rose between 9–18% on standalone and consolidated bases, highlighting margin expansion and operational leverage despite flat headline sales; the company finished FY26 debt-free with a cash treasury of ~INR190 crores and recommended an INR8.50 per share dividend. Operationally, the company completed Phase I ATBS expansion to a 50,000 MT scale and reported ATBS utilisation near 75–80%, while targeting ~15% company-level volume growth for FY27 and earmarking INR200–250 crores capex for FY27 focused on downstream, product development and debottlenecking, underscoring strong growth visibility tied to capacity investment. Market dynamics show Vinati Organics competing against aggressive Chinese pricing and cyclic end-market destocking, yet it retains structural strengths in niche, high-purity chemistries and differentiated feedstock control; management expects antioxidants and IB/butyl-phenol downstream integration to drive medium-term revenue expansion to INR800–900 crores in the antioxidants roadmap over the next two years. Risk and mitigation highlights include earlier IBB disruption due to geopolitical raw material constraints which is now resolved, an ongoing process reengineering at VOPL expected to restore full production by Q3 FY27, and active R&D and backward-integration moves to protect margins and secure feedstock, indicating practical risk management rather than speculative guidance.
Over the past 52 weeks, Vinati Organics Ltd has traded between a low of ₹1,062.20 and a high of ₹1,713.35. The 52-week high and low indicate the stock’s price range over the last year and help investors understand its volatility and recent trading levels.
Vinati Organics Ltd has a market capitalization of approximately 11,092.22. Market capitalization represents the total value of a company’s outstanding shares and helps investors understand its size, stability, and relative risk compared to other listed companies.
Vinati Organics Ltd’s investment profile depends on its business fundamentals, valuation, and long-term outlook. The stock currently trades at a PE ratio of 24.74 and operates in the its sector sector. Investors typically assess financial performance, growth prospects, and individual risk tolerance before making investment decisions.
Based on its market capitalization of 11,092.22 Cr, Vinati Organics Ltd is classified as a Small Cap stock. Large-cap stocks are generally more stable, while mid-cap and small-cap stocks tend to offer higher growth potential along with higher price volatility.
Vinati Organics Ltd operates in the its sector sector. Sector classification matters because companies in the same sector are often affected by similar economic conditions, regulatory changes, and competitive dynamics, which can influence overall stock performance.
The Price-to-Earnings (PE) ratio of Vinati Organics Ltd is 24.74. The PE ratio compares a company’s share price to its earnings and is commonly used to assess valuation. Comparing the PE ratio with sector peers and historical levels provides better context.
Consolidated net profit for Q1FY27 was ₹108.86 crore, up 4.5% year-on-year from ₹104.19 crore.
One reported snapshot showed Q4 FY26 PAT at ₹123.86 crore on revenue from operations of ₹624.31 crore, while another cited ₹150.24 crore profit on ₹500.65 crore revenue.
For the quarter ended March 2026, sales were Rs 603.92 crore and net profit was Rs 123.86 crore.
The Union Budget 2026 proposes dedicated chemical parks on a plug-and-play model, which can significantly reduce setup costs, streamline approvals, and improve operational efficiency for Vinati Organics' ongoing and future capacity expansions.
| Symbol | Watchlist | Price | Market Cap | P/E | P/B | Div Yield (%) | ROE (%) | ROCE (%) | ROA (%) |
3069.15 | 13,285 Cr | 21.30 | 3.36 | 0.81 | 10.62 | 14.23 | 7.62 | ||
3247.35 | 12,685 Cr | 37.09 | 8.98 | 0.31 | 23.19 | 21.43 | 10.79 | ||
1102.85 | 12,556 Cr | 55.81 | 3.80 | 0.14 | 5.10 | 7.68 | 2.81 | ||
1070.00 | 11,092 Cr | 24.74 | 3.51 | 0.79 | 14.03 | 18.72 | 12.49 | ||
12234.00 | 9,699 Cr | 54.62 | 8.79 | 0.06 | 16.09 | 21.42 | 13.50 | ||
601.70 | 9,584 Cr | 31.05 | 2.99 | 0.83 | 8.89 | 10.37 | 5.63 | ||
1634.75 | 8,361 Cr | 41.55 | 5.45 | 0.61 | 11.74 | 15.60 | 11.88 | ||
| Median: 7 Co. | — | 1634.75 | 11,092 Cr | 37.09 | 3.80 | 0.61 | 11.74 | 15.60 | 10.79 |
